Oak Ridge Investments LLC Purchases 2,227 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Oak Ridge Investments LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,946 shares of the healthcare conglomerate’s stock after purchasing an additional 2,227 shares during the quarter. UnitedHealth Group accounts for about 1.7% of Oak Ridge Investments LLC’s portfolio, making the stock its 11th largest position. Oak Ridge Investments LLC’s holdings in UnitedHealth Group were worth $21,219,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Pacer Advisors Inc. increased its position in UnitedHealth Group by 5.7% during the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after acquiring an additional 3,525 shares during the last quarter. Garden State Investment Advisory Services LLC grew its holdings in UnitedHealth Group by 13.5% during the 2nd quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate’s stock valued at $536,000 after purchasing an additional 125 shares during the last quarter. Columbus Hill Capital Management L.P. bought a new stake in UnitedHealth Group in the second quarter worth about $14,789,000. Summit Trail Advisors LLC raised its holdings in shares of UnitedHealth Group by 33.3% in the second quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate’s stock worth $6,115,000 after buying an additional 2,999 shares during the period. Finally, Transatlantique Private Wealth LLC boosted its holdings in UnitedHealth Group by 9.9% during the 2nd quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate’s stock valued at $1,291,000 after acquiring an additional 234 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on UNH shares. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens raised their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, KeyCorp reiterated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $510.03 on Friday. The company has a market cap of $469.37 billion, a PE ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The business has a 50-day simple moving average of $549.37 and a two-hundred day simple moving average of $562.73. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.83 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.